目的:验证和研究欧洲癌症研究与治疗组织(European Organization for Research and Treatment of Cancer,EORTC)风险量表对我国接受术后即刻膀胱灌注化疗的非肌层浸润性膀胱癌(nonmuscle invasive bladder cancer,NMIBC)患者预后判断的...
初次诊断的膀胱泌尿上皮细胞癌(urothelial carcinoma of the bladder,UCB,简称"膀胱癌")中约20%为肌层浸润性膀胱癌(muscle-invasive bladdercancer,MIBC),80%为非肌层浸润性膀胱癌;后者术后约20%~30%的病例进展为MIBC;合计约40...